Society News Archive

3 March 2016
NRC Approves Mo-99 Production Facility Construction

The Nuclear Regulatory Commission (NRC) has authorized its staff to issue a construction permit for a first-of-a-kind facility dedicated to medical isotope production. The permit will allow SHINE Medical Technologies™(SHINE) to build the facility for the production of molybdenum-99 and other radioisotopes. The facility will be located in Janesville, Wisconsin, about 64 kilometers southeast of Madison.

SHINE will submit a separate operating license application for NRC approval before it can start production. There is additional information on the SHINE website.